Biomarin Pharmaceutical (BMRN) Free Cash Flow (2009 - 2026)
Biomarin Pharmaceutical's Free Cash Flow came in at $139.29 million for Q2 2026, down 17.2% from $168.17 million a year earlier and down 30.3% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Free Cash Flow (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biomarin Pharmaceutical reported Free Cash Flow of $738.18 million, up 6.2% year-over-year; for FY2025, it came in at $724.96 million, up 48.7% from FY2024.
- Free Cash Flow has increased in each of the last three years.
- Going back by year, Free Cash Flow was $487.42 million in FY2024 (+679.0%), $62.57 million in FY2023 (+13.9%), $54.94 million in FY2022 (-73.7%) and $208.96 million in FY2021.
- The five-year range for quarterly Free Cash Flow is -$98.39 million (Q1 2023) to $340.24 million (Q3 2025).
- Year-over-year, Free Cash Flow increased in five of the last seven quarters, with growth averaging 117.0%.
- The fastest year-over-year change in Free Cash Flow over five years came in Q1 2025 (growth of 655.4%), and the weakest in Q4 2025 (a decline of 64.5%).
- Business Quant data shows BMRN's Free Cash Flow at $199.73 million (Q1 2026), $58.92 million (Q4 2025) and $340.24 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.30 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.11 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 4.48 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 6.20 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 5.34 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.43 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 302.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.01 Bn |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn | 139.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 139.29 Mn |
| Mar 31, 2026 | 199.73 Mn |
| Dec 31, 2025 | 58.92 Mn |
| Sep 30, 2025 | 340.24 Mn |
| Jun 30, 2025 | 168.17 Mn |
| Mar 31, 2025 | 157.63 Mn |
| Dec 31, 2024 | 166.10 Mn |
| Sep 30, 2024 | 203.02 Mn |
| Jun 30, 2024 | 97.44 Mn |
| Mar 31, 2024 | 20.87 Mn |
| Dec 31, 2023 | -1.43 Mn |
| Sep 30, 2023 | 113.91 Mn |
| Jun 30, 2023 | 48.48 Mn |
| Mar 31, 2023 | -98.39 Mn |
| Dec 31, 2022 | -28.90 Mn |
| Sep 30, 2022 | 129.02 Mn |
| Jun 30, 2022 | 29.07 Mn |
| Mar 31, 2022 | -74.25 Mn |
| Dec 31, 2021 | -17.56 Mn |
| Sep 30, 2021 | 78.33 Mn |
API Access
Biomarin Pharmaceutical Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();